HMG-CoA reductase inhibitorsplatelet aggregation inhibitorsSystemic glucocorticoidsIHIOpolypharmacyIran Health Insurance Organization
…s were the most commonly used medications (50.02%), followed by HMG-CoA reductase inhibitors (42.73%) and platelet aggregation inhibitors (41.92%). Polyphar…